SecurityCEMP / Cempra, Inc. (58549G100)
President and CEOWechsler Daniel Mark
IndustryPharmaceutical Preparations
Institutional Owners85
Institutional Shares18,608,528 - 59.35%
Common Shares Outstanding31,353,254 shares (as of 2018-03-31)
Institutional Value$ 161,164,000 USD
Related MLNT / Melinta Therapeutics, Inc.

Institutional Stock Ownership and Shareholders

CEMP / Cempra, Inc. Institutional Ownership

Cempra, Inc. (NASDAQ:CEMP) has 85 institutional investors and shareholders that have filed 13D/G or 13F forms with the Securities Exchange Commission (SEC). These institutions hold a total of 18,608,528 shares. Largest shareholders include Vatera Holdings Llc, Deerfield Management Co, FMR LLC / Fidelity, BlackRock Inc., Vanguard Group Inc, Dimensional Fund Advisors Lp, Millennium Management Llc, Pennsylvania Trust Co, Wellington Management Group LLP, and Sphera Funds Management Ltd..
Cempra, Inc. (NASDAQ:CEMP) ownership structure shows current positions in the company by institutions and funds, as well as latest changes in position size. Major shareholders can include individual investors, mutual funds, hedge funds, or institutions. The Schedule 13D indicates that the investor holds more than 5% of the company and intends to actively pursue a change in business strategy. Schedule 13G indicates a passive investment of over 5%. Green rows indicate new positions. Red rows indicate closed positions. Click the link icon to see the full transaction history.

Embed this chart! (it updates automatically)
<a href="https://fintel.io/so/us/cemp"><img src="https://images.fintel.io/us-cemp-so.png" alt="CEMP / Cempra, Inc. Institutional Ownership"><a>

File DateFormInvestor Opt Prev
Shares
Current
Shares
Change
(Percent)
Prev Value
($1000)
Current Value
($1000)
Change
(Percent)
2018-05-11 13F-HR Covington Capital Management 200 0 -100.00 3 0 -100.00
2018-05-10 13F-HR MCF Advisors LLC 400 400 0.00 6 3 -50.00
2018-05-11 13F-HR DIMENSIONAL FUND ADVISORS LP 430,428 476,212 10.64 6,801 3,524 -48.18
2018-05-15 13F-HR Advisor Group, Inc. 200 200 0.00 3 1 -66.67
2018-05-15 13F-HR CALIFORNIA STATE TEACHERS RETIREMENT SYSTEM 15,515 23,035 48.47 245 170 -30.61
2018-05-03 13F-HR MEEDER ASSET MANAGEMENT INC 723 0 -100.00 11 0 -100.00
2018-05-15 13F-HR DEERFIELD MANAGEMENT CO 3,127,846 23,146
2018-05-14 13F-HR Renaissance Technologies LLC 82,320 117,683 42.96 1,301 871 -33.05
2018-05-15 13F-HR BALYASNY ASSET MANAGEMENT LLC 10,237 0 -100.00 162 0 -100.00
2018-05-14 13F-HR NORTHWESTERN MUTUAL WEALTH MANAGEMENT CO 1,757 1,757 0.00 28 13 -53.57
2018-05-15 13F-HR PANAGORA ASSET MANAGEMENT INC 68,012 56,490 -16.94 1,075 418 -61.12
2018-05-15 13F-HR Tower Research Capital LLC (TRC) 602 4,301 614.45 9 32 255.56
2018-05-15 13F-HR MILLENNIUM MANAGEMENT LLC 278,915 446,713 60.16 4,407 3,306 -24.98
2018-05-14 13F-HR Perigon Wealth Management, LLC 301 2
2018-05-10 13F-HR NEW YORK STATE COMMON RETIREMENT FUND 9,380 9,380 0.00 148 69 -53.38
2018-05-15 13F-HR TWO SIGMA INVESTMENTS LLC 14,851 0 -100.00 235 0 -100.00
2018-05-15 13F-HR Parallax Volatility Advisers, L.P. 1,470 0 -100.00 23 0 -100.00
2018-04-18 13F-HR Creative Planning 13,292 98
2018-05-15 13F-HR Cubist Systematic Strategies, LLC 9,000 67
2018-05-15 13F-HR BARCLAYS PLC Call 1,660 2,000 20.48 26 15 -42.31
2018-05-15 13F-HR OXFORD ASSET MANAGEMENT 22,482 166
2018-05-17 13F-HR Legal & General Group Plc 2,722 2,646 -2.79 43 20 -53.49
2018-05-15 13F-HR SUSQUEHANNA INTERNATIONAL GROUP, LLP Put 151,200 86,300 -42.92 2,389 639 -73.25
2018-05-07 13F-HR AMERICAN INTERNATIONAL GROUP INC 6,454 9,669 49.81 102 72 -29.41
2018-05-15 13F-HR LADENBURG THALMANN FINANCIAL SERVICES INC 246 200 -18.70 4 1 -75.00
2018-05-14 13F-HR TEACHERS ADVISORS INC 17,348 17,348 0.00 274 128 -53.28
2018-05-02 13F-HR RHUMBLINE ADVISERS 10,186 12,575 23.45 161 93 -42.24
2018-05-09 13F-HR GABELLI FUNDS LLC 38,400 28,400 -26.04 607 210 -65.40
2018-05-15 13F-HR Man Group plc 153,541 1,136
2018-05-18 13F-HR/A ROYAL BANK OF CANADA 633 27 -95.73 10 0 -100.00
2018-05-15 13F-HR SUSQUEHANNA INTERNATIONAL GROUP, LLP Call 44,500 22,400 -49.66 703 166 -76.39
2018-05-15 13F-HR Bank of New York Mellon Corp 37,414 55,875 49.34 592 413 -30.24
2018-05-15 13F-HR MANUFACTURERS LIFE INSURANCE COMPANY, THE 8,398 13,046 55.35 133 97 -27.07
2018-05-14 13F-HR MORGAN STANLEY 42,718 71,340 67.00 675 527 -21.93
2018-05-15 13F-HR A.R.T. Advisors, LLC 59,166 19,260 -67.45 934 142 -84.80
2018-05-09 13F-HR NORTHERN TRUST CORP 112,223 166,112 48.02 1,774 1,229 -30.72
2018-05-15 13F-HR PDT Partners, LLC 11,273 0 -100.00 178 0 -100.00
2018-05-01 13F-HR PUBLIC EMPLOYEES RETIREMENT ASSOCIATION OF COLORADO 2,476 2,476 0.00 39 18 -53.85
2018-05-03 13F-HR BRONFMAN E.L. ROTHSCHILD, L.P. 600 4
2018-05-09 13F-HR Teton Advisors, Inc. 15,000 15,500 3.33 237 115 -51.48
2018-05-15 13F-HR BANK OF AMERICA CORP /DE/ 38,834 35,871 -7.63 614 266 -56.68
2018-05-14 13F-HR ALLIANCEBERNSTEIN L.P. 17,740 19,840 11.84 280 147 -47.50
2018-05-11 13F-HR CITIGROUP INC 2,142 5,084 137.35 33 38 15.15
2018-05-11 13F-HR STIFEL FINANCIAL CORP 151,415 1,120
2018-05-08 13F-HR Advisornet Financial, Inc 200 200 0.00 3 1 -66.67
2018-05-11 13F-HR PNC FINANCIAL SERVICES GROUP, INC. 64 72 12.50 2 0 -100.00
2018-05-15 13F-HR GEODE CAPITAL MANAGEMENT, LLC 80,561 139,823 73.56 1,272 1,034 -18.71
2018-05-09 13F-HR BlackRock Inc. 604,455 857,398 41.85 9,550 6,344 -33.57
2018-05-15 13F-HR BRIDGEWAY CAPITAL MANAGEMENT INC 78,140 39,240 -49.78 1,235 290 -76.52
2018-04-11 13F-HR FRANKLIN STREET ADVISORS INC /NC 12,910 13,050 1.08 204 97 -52.45
2018-05-02 13F-HR WELLS FARGO & COMPANY/MN 7,789 5,979 -23.24 123 45 -63.41
2018-05-15 13F-HR VANGUARD GROUP INC 522,074 821,449 57.34 8,249 6,078 -26.32
2018-05-15 13F-HR Squarepoint Ops LLC 17,100 127
2018-05-09 13F-HR FEDERATED INVESTORS INC /PA/ 2,442 550 -77.48 39 4 -89.74
2018-05-07 13F-HR SCHWAB CHARLES INVESTMENT MANAGEMENT INC 47,621 74,668 56.80 753 553 -26.56
2018-05-15 13F-HR Ameritas Investment Partners, Inc. 771 771 0.00 12 6 -50.00
2018-05-04 13F-HR Formidable Asset Management, LLC 100 0 -100.00 0 0
2018-04-20 13F-HR STRS OHIO 2,700 4,300 59.26 42 31 -26.19
2018-04-23 13F-HR Sterling Investment Advisors, Ltd. 95 95 0.00 2 1 -50.00
2018-05-15 13F-HR GOLDMAN SACHS GROUP INC 31,028 17,757 -42.77 490 131 -73.27
2018-05-10 13F-HR CALIFORNIA PUBLIC EMPLOYEES RETIREMENT SYSTEM 15,560 15,560 0.00 246 115 -53.25
2018-05-15 13F-HR Wellington Management Group LLP 293,924 2,175
2018-05-15 13F-HR HONKAMP KRUEGER FINANCIAL SERVICES INC /ADV 30 0
2018-05-15 13F-HR WOLVERINE TRADING, LLC 26,021 193
2018-05-15 13F-HR WOLVERINE TRADING, LLC Call 37,100 0 -100.00 586 0 -100.00
2018-05-11 13F-HR Cutler Group LP Call 8,200 0 -100.00 0 0
2018-05-14 13F-HR TIAA CREF INVESTMENT MANAGEMENT LLC 77,011 24,097 -68.71 1,217 178 -85.37
2018-04-13 13F-HR BANK OF MONTREAL /CAN/ 7,770 7,939 2.18 123 58 -52.85
2018-05-15 13F-HR SUSQUEHANNA INTERNATIONAL GROUP, LLP 33,921 20,285 -40.20 536 150 -72.01
2018-05-11 13F-HR Cutler Group LP 36 36 0.00 0 0
2018-05-14 13F-HR AMERIPRISE FINANCIAL INC 15,173 0 -100.00 240 0 -100.00
2018-05-08 13F-HR US BANCORP \DE\ 218 2
2018-05-11 13F-HR CITIGROUP INC Put 2,800 100 -96.43 44 1 -97.73
2018-05-10 13F-HR South Dakota Investment Council 129,941 129,941 0.00 2,053 962 -53.14
2018-05-14 13F-HR FMR LLC / Fidelity 989,509 989,509 0.00 15,634 7,322 -53.17
2018-05-11 13F-HR BNP PARIBAS ARBITRAGE, SA 2,667 2,951 10.65 42,139 21,837 -48.18
2018-05-14 13F-HR/A CITADEL ADVISORS LLC 18,741 11,874 -36.64 296 88 -70.27
2018-05-15 13F-HR Palo Alto Investors, LLC 50,689 50,689 0.00 801 375 -53.18
2018-05-15 13F-HR WOLVERINE TRADING, LLC Put 10,500 24,800 136.19 166 184 10.84
2018-05-14 13F-HR/A CITADEL ADVISORS LLC Put 14,900 11,800 -20.81 246 87 -64.63
2018-05-15 13F-HR UBS Group AG 3,787 1,754 -53.68 59 13 -77.97
2018-05-14 13F-HR Eversept Partners, Llc 76,837 569
2018-04-18 13F-HR OGOREK ANTHONY JOSEPH /NY/ /ADV 60 60 0.00 0 0
2018-05-15 13F-HR GOLDMAN SACHS GROUP INC Put 1,060 0 -100.00 17 0 -100.00
2018-05-15 13F-HR Point72 Asia (Hong Kong) Ltd 1,067 8
2018-05-11 13F-HR MACQUARIE GROUP LTD 24 0 -100.00 0 0
2018-05-10 13F-HR SPHERA FUNDS MANAGEMENT LTD. 200,000 243,896 21.95 3,160 1,805 -42.88
2018-05-15 13F-HR BARCLAYS PLC Put 280 0 -100.00 4 0 -100.00
2018-05-14 13F-HR PARAMETRIC PORTFOLIO ASSOCIATES LLC 10,641 10,052 -5.54 168 74 -55.95
2018-05-10 13F-HR JP Morgan Chase & Co 2,274 3,281 44.28 36 25 -30.56
2018-05-10 13F-HR Stratos Wealth Partners, LTD. 100 1
2018-05-15 13F-HR HIGHBRIDGE CAPITAL MANAGEMENT LLC 14,620 108
2018-04-06 13F-HR Pennsylvania Trust Co 299,420 2,216
2018-05-15 13F-HR GOLDMAN SACHS GROUP INC Call 2,880 0 -100.00 46 0 -100.00
2018-04-25 13F-HR TOTH FINANCIAL ADVISORY CORP 60 0 -100.00 1 0 -100.00
2018-05-11 13F-HR ONTARIO TEACHERS PENSION PLAN BOARD 14,537 0
2018-05-10 13F-HR Vatera Holdings Llc 6,729,459 8,729,459 29.72 106,325 64,598 -39.24
2018-05-07 13F-HR Engineers Gate Manager LP 21,153 157
2018-05-15 13F-HR STATE STREET CORP 161,485 192,671 19.31 2,552 1,429 -44.00
2018-05-11 13F-HR CITADEL ADVISORS LLC Put 11,800 87
2018-05-11 13F-HR CITADEL ADVISORS LLC 11,874 88
2018-05-09 13F-HR Bellevue Group AG 32,100 0 -100.00 507 0 -100.00
2018-04-23 13F-HR Financial Architects, Inc 160 160 0.00 3 1 -66.67
2018-05-15 13F-HR DEUTSCHE BANK AG\ 92,751 58,771 -36.64 1,464 434 -70.36
2018-02-09 13F-HR RidgeWorth Capital Management LLC 22,054 348
2018-05-11 13F-HR CITIGROUP INC Call 9,360 0 -100.00 148 0 -100.00
2018-05-15 13F-HR BARCLAYS PLC 31,512 10,210 -67.60 498 74 -85.14
2018-05-08 13F-HR Alambic Investment Management, L.P. 13,082 0 -100.00 207 0 -100.00
2018-04-20 13F-HR Steward Partners Investment Advisory, Llc 4,780 4,780 0.00 75 35 -53.33
2018-02-14 13F-HR NUMERIC INVESTORS LLC 187,301 2,959
2018-05-14 13F-HR VIRTUS ETF ADVISERS LLC 22,054 49,028 122.31 348 363 4.31

Related Articles

ARWR: Arrowhead Pharmaceuticals Analysis and Research Report

21h - Asif

Business Arrowhead develops medicines that treat intractable diseases by silencing the genes that cause them. Using a broad portfolio of RNA chemistries and efficient modes of delivery, Arrowhead therapies trigger the RNA interference mechanism to induce rapid, deep and durable knockdown of target genes. RNA interference, or RNAi, is a mechanism present in living cells that inhibits the expression of a specific gene, thereby affecting the production of a specific protein. Deemed to be one of the most important recent discoveries in life science with the potential to transform medicine, the discoverers of RNAi were awarded a Nobel Prize in 2006 for their work. Arrowhead’s RNAi-based therapeutics leverage this natural pathway of gene silencing. In fiscal 2017, Arrowhead refocused its resources on therapeutics that exclusively utilize the company’s Targeted RNAi Molecule (TRiMTM) platform technology. Therapeutics built on the TRiMTM platform have demonstrated high levels of pha...

PRTO: Proteon Therapeutics Analysis and Research Report

2018-06-11 - Asif

Overview Proteon Therapeutics is a late-stage biopharmaceutical company focused on the development of novel, first-in-class pharmaceuticals to address the needs of patients with renal and vascular disease. The company's product candidate, vonapanitase, is a recombinant human elastase that Proteon Therapeutics is developing to improve vascular access outcomes in patients with chronic kidney disease, or CKD, undergoing or planning for hemodialysis, a lifesaving treatment that cannot be conducted without a functioning vascular access. The company believe data from its completed Phase 2 and Phase 3 clinical trials of vonapanitase support that a one-time, local application of investigational vonapanitase during surgical creation of a radiocephalic fistula for hemodialysis may improve fistula use for hemodialysis and secondary patency (time to fistula abandonment), thereby improving patient outcomes and reducing the burden on patients and the healthcare system. Arteriovenous fistu...

GALE: Galena Biopharma Analysis and Research Report

2018-06-11 - Asif

Overview Galena Biopharma is a clinical-stage biopharmaceutical company focused on novel cancer immunotherapeutics for a broad range of cancer indications. The company's lead product candidate, galinpepimut-S, or GPS, is a cancer i unotherapeutic agent licensed from Memorial Sloan Kettering Cancer Center, or MSK, that targets the Wilms tumor 1, or WT1, protein, which is present in 20 or more cancer types. Based on its mechanism of action as a directly immunizing agent, GPS has the potential as a monotherapy or in combination with other immunotherapeutic agents to address a broad spectrum of hematologic, or blood, cancers and solid tumor indications. Phase 2 clinical trials for GPS have been completed and Galena Biopharma has planned Phase 3 clinical trials (pending funding availability) for two indications, acute myeloid leukemia, or AML, and malignant pleural mesothelioma, or MPM. GPS is also in development as a potential treatment for multiple myeloma, or MM, and ovarian can...

Related News Stories

Achaogen: Contrarian Play At An Inflection Point

2018-03-22 seekingalpha
Investing in antibiotics for high-need indications is a deeply contrarian move, motivated by shifting epidemiological and pharmacoeconomic dynamics. (69-7)

Paratek: A Review Of Progress And Preview Of 2018

2018-03-21 seekingalpha
Paratek Pharmaceuticals (PRTK) is a biopharmaceutical company making steady progress towards approval of its novel tetracycline antibiotic, omadacycline. Omadacycline produced impressive results in three phase 3 studies, the results of which, coupled with other progress, can no longer be seen in the share price. (168-0)

CUSIP: 58549G100